Note 1 - Business and Organization (Details Textual) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Sep. 15, 2025 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Proceeds from divestiture of businesses | $ 18,392,000 | $ 0 | |||
| Escrow Deposit | $ 19,653,000 | 19,653,000 | $ 19,411,000 | ||
| Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member] | Oncology Transaction [Member] | Labcorp [Member] | |||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
| Cash consideration | $ 192,500,000 | ||||
| Proceeds from divestiture of businesses | 18,400,000 | ||||
| Escrow Deposit | $ 19,200,000 | ||||
| Performance based earnout consideration received | 32,500,000 | ||||
| Earnout consideration receivable | $ 0 | $ 0 | |||